Prevention & care

Chronic kidney disease: chronicity, filtration, albumin, stages, and care

7 sources · Latest source check 2026-10-20 UTC

On this page

Chronic kidney disease means persistent abnormalities of kidney structure or function that have health implications. “Chronic” requires evidence over at least three months, rather than one unexpected blood result. Early disease may cause few symptoms, so symptoms alone do not report kidney function or damage.[1]

Filtration categories are only part of CKD classification

Filtration categories are only part of CKD classification
G category	GFR in mL/min/1.73 m²	Description
G1	90 or higher	Normal or high filtration.[2]
G2	60–89	Mild decrease.[2]
G3a	45–59	Mild to moderate decrease.[2]
G3b	30–44	Moderate to severe decrease.[2]
G4	15–29	Severe decrease.[2]
G5	Below 15	Kidney failure category.[2]

Cause, filtration, and damage belong together

KDIGO classifies CKD by cause, GFR category and albuminuria category, often abbreviated CGA. G1 or G2 alone does not establish CKD without evidence of kidney damage. A filtration number and a urine protein finding describe different aspects of the condition.[2]

The guideline warns against assuming chronicity from a single abnormal eGFR or albumin-creatinine ratio. An acute kidney problem may produce abnormal results too. The three-month definition is not an instruction to delay assessment of a new or potentially serious illness.[2]

Estimated filtration is a calculated measurement

Most routine eGFR results estimate filtration using a blood marker, commonly creatinine, and an equation. Creatinine is related to muscle metabolism, so its interpretation needs context. Measured GFR is a different, more involved test; an estimate and direct measurement should not be treated as identical methods.[4]

MedlinePlus also describes cystatin C as another blood marker used in estimation. Which marker or combined approach is useful depends on the setting. A change in a calculated value needs interpretation with the person’s condition and other results, rather than assuming it always represents the same amount of permanent kidney damage.[4]

Urine albumin answers another question

Albumin is a blood protein that normally passes into urine only in small amounts. The urine albumin-creatinine ratio compares albumin with urine creatinine to help assess protein leakage. This differs from blood creatinine used in eGFR: the similar word does not make the two tests interchangeable.[5]

A urine protein result can identify a damage marker even when filtration is relatively preserved. Results are interpreted with repeat testing and clinical circumstances. The question is not merely whether either number falls outside a lab range, but what the pattern and its persistence indicate.[5]

Management follows the cause and the wider health picture

CKD can relate to diabetes, high blood pressure, inflammatory kidney disorders or inherited conditions, among other causes. Complications can include cardiovascular problems, anaemia, acid-base changes and disturbances of minerals or potassium. A stage label alone does not identify the cause or specify every treatment.[1]

NIDDK describes monitoring blood pressure, filtration, urine albumin and other relevant findings. Medicines and doses may need review, and food or fluid advice can require individualisation. The goal is an informed plan and follow-up, rather than assuming a supplement can “flush” the kidneys or that every stage needs identical restrictions.[6]

Changes over time matter. NIDDK encourages discussing how current results compare with earlier ones and which treatment decisions they affect. This page explains the information to understand, without interpreting a personal laboratory panel or deciding when an individual needs dialysis or a transplant.[6]

Stage and a time-specific risk estimate answer different questions

CKD staging describes kidney-function and urine-albumin categories. The Kidney Failure Risk Equation—KFRE—estimates the chance of needing dialysis or a kidney transplant over two or five years in defined CKD populations. Its four-variable version combines age, sex, eGFR and urine ACR, rather than using the stage name alone.[7]

Evidence & uncertainty

The KDIGO 2024 guideline provides the selected classification and care framework. Its website currently reports a focused treatment update underway for emerging evidence in CKD without diabetes. That update is not treated as a completed recommendation set, and this overview does not independently regrade the guideline evidence.[3]

Selected-source overview · Independent review pending

Published questions

Does one low eGFR result prove chronic kidney disease?

Selected-source overview · Independent review pending. Read the evidence context.

No. Chronicity and the clinical context need assessment. KDIGO warns that one abnormal result may reflect an acute problem rather than established CKD.[2]

Evidence behind this answer

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
clinical practice guideline · 2024
Selected original guideline tables and chronicity passages inspected · PDF page 22 Tables 1–3 and page 34 practice points 1.1.3.1–1.1.3.2: criteria, G categories and chronicity